Companies / CRL vs IQV
CRL vs IQV: Charles River Laboratories International and IQVIA Holdings
Charles River Laboratories International (CRL) reported $4.0B in revenue against a -3.6% net margin, while IQVIA Holdings (IQV) reported $16.3B at a 8.3% net margin, most recently.
| Metric | CRL | IQV |
|---|---|---|
| Revenue | $4.0B | $16.3B |
| Net Income | $-0.1B | $1.4B |
| Gross Margin | — | — |
| Operating Margin | 0.6% | 13.4% |
| EPS (Diluted) | $-2.91 | $7.84 |
| Free Cash Flow | $0.5B | $2.1B |
| Total Debt | $2.1B | $15.9B |
| P/E Ratio | n/m | 28.7× |
| P/B Ratio | 3.2× | 5.9× |
| Stock Price | $312.87 | $264.88 |
Free: last 5 years
| Fiscal year | FY2011 🔒 | FY2012 🔒 | FY2013 🔒 | FY2014 🔒 | FY2015 🔒 | FY2016 🔒 | FY2017 🔒 | FY2018 🔒 | FY2019 🔒 | FY2020 🔒 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CRL Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $3.5B | $4.0B | $4.1B | $4.0B | $4.0B |
| IQV Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $13.9B | $14.4B | $15.0B | $15.4B | $16.3B |